Pfizer 

ARS7.23
+ARS0+0% Friday 19:20

统计数据

当日最高
7.5
当日最低
7.2
52周最高
8.3
52周最低
6.47
成交量
2,831
平均成交量
1,893
市值
-
市盈率
-
股息收益率
5,752.62%
股息
415.91

即将到来

股息

5,752.62%股息收益率
10年增长
56.81%
5年增长
62.54%
3年增长
72.94%
1年增长
79.02%

收益

4Feb预期
Q2 2024
Q3 2024
下一个
367.55
594.04
820.54
1,047.03
预期每股收益
479.9306157625
实际每股收益
N/A

人们还关注

此列表基于关注PFED.BA的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Show more...
首席执行官
Dr. Albert Bourla D.V.M., DVM, Ph.D.
员工
79000
国家
United States
ISIN
ARDEUT111424

上市公司